Carl Zeiss Meditec: Goldman Sachs holding rises to 5.02%

Goldman Sachs Group said its total position in Carl Zeiss Meditec rose to 5.02% from 4.83% on Sept. 23, 2026. The stake includes 0.54% of voting rights attached to shares and 4.48% through instruments.